Group 1 - The core point of the news is that southbound funds have increased their holdings in Jinxin Reproductive Medicine (01951.HK) by 1.466 million shares on November 13, 2025, with a total net increase of 4.3525 million shares over the last five trading days [1] - Over the past 20 trading days, there have been 11 days of net increases in holdings by southbound funds, totaling 13.1125 million shares [1] - As of now, southbound funds hold 1.448 billion shares of Jinxin Reproductive Medicine, accounting for 52.5% of the company's issued ordinary shares [1] Group 2 - The company, Jinxin Reproductive Medicine, is an investment holding company primarily providing in vitro fertilization (IVF) services [2] - The company offers a range of services through its subsidiaries, including assisted reproductive services, management services, mobile surgical center facilities, auxiliary medical services, and sales of medical consumables and equipment [2] - Jinxin Reproductive Medicine operates mainly in China and the United States [2]
锦欣生殖（01951.HK）：11月13日南向资金增持146.6万股